Bio View Valuation
| BIOV Stock | ILS 27.90 0.10 0.36% |
At this time, the firm appears to be overvalued. Bio View shows a prevailing Real Value of S24.95 per share. The current price of the firm is S27.9. Our model approximates the value of Bio View from analyzing the firm fundamentals such as Profit Margin of 0.04 %, current valuation of 35.4 M, and Return On Equity of 0.0399 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Bio View's price fluctuation is very steady at this time. Calculation of the real value of Bio View is based on 3 months time horizon. Increasing Bio View's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bio View is useful when determining the fair value of the Bio stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bio View. Since Bio View is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio View's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.9 | Real 24.95 | Hype 27.9 | Naive 26.23 |
The real value of Bio Stock, also known as its intrinsic value, is the underlying worth of Bio View Company, which is reflected in its stock price. It is based on Bio View's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bio View's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bio View's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bio View helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio View more accurately as focusing exclusively on Bio View's fundamentals will not take into account other important factors: Bio View Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Bio View's current stock value. Our valuation model uses many indicators to compare Bio View value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio View competition to find correlations between indicators driving Bio View's intrinsic value. More Info.Bio View is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about 1.00 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio View by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio View's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio View's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bio View's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bio View and how it compares across the competition.
About Bio View Valuation
The stock valuation mechanism determines the current worth of Bio View on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bio View. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bio View based exclusively on its fundamental and basic technical indicators. By analyzing Bio View's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bio View's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio View. We calculate exposure to Bio View's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio View's related companies.BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Bio View's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bio View's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bio View's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bio View's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bio View's revenue streams: Identify Bio View's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bio View's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bio View's growth potential: Evaluate Bio View's management, business model, and growth potential.
- Determine Bio View's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bio View's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |